Asia-Pacific Viscosupplementation Market to Reach USD 3.80 Billion by 2033 –

Increasing Aging Population and Preference for Minimally Invasive Treatments Propel Market Momentum

According to the latest report by Renub Research , the Asia-Pacific Viscosupplementation Market is projected to grow from USD 1.60 billion in 2024 to USD 3.80 billion by 2033, expanding at a CAGR of 10.1% from 2025 to 2033. This significant growth is being fueled by the rising prevalence of osteoarthritis (OA), an aging demographic, and the growing consumer shift toward non-invasive and non-surgical therapeutic options for joint pain relief.

Osteoarthritis: A Growing Healthcare Challenge in the Asia-Pacific Region

Osteoarthritis is rapidly becoming a major public health concern across Asia-Pacific due to increasing life expectancy, sedentary lifestyles, and rising obesity rates. According to medical research, over 300 million people globally are affected by osteoarthritis, and a significant share of that population resides in the Asia-Pacific region.

Countries such as China, India, Japan, and South Korea are witnessing a surge in knee and hip osteoarthritis cases, especially among adults over 50. The physical and economic burden of OA is pushing both healthcare providers and patients to explore safer, more affordable, and effective treatment options—driving the demand for viscosupplementation therapies.

What is Viscosupplementation?

Viscosupplementation is a minimally invasive procedure that involves injecting hyaluronic acid (HA) into the synovial joint (typically the knee) to improve lubrication, reduce pain, and enhance joint mobility. This treatment helps delay or even avoid the need for knee replacement surgery in many patients.

Viscosupplements are considered an ideal therapy for patients with mild to moderate OA, offering lower recovery times, fewer complications, and improved quality of life without the risks associated with surgical intervention.

Shift Toward Non-Surgical and Minimally Invasive Solutions

One of the most significant trends driving market growth is the increasing preference for non-surgical treatment options among aging populations in countries like Japan and South Korea, as well as urban populations in China and India. Patients are now seeking therapies that provide relief with minimal disruption to their daily lives, making viscosupplementation a preferred choice.

Moreover, rising awareness about the benefits of early OA management is pushing patients and healthcare providers to adopt early intervention therapies, which include viscosupplementation before joint degeneration becomes severe enough to warrant surgery.

Expansion of Healthcare Access and Reimbursement Support

The Asia-Pacific region is experiencing improved healthcare access and insurance coverage, particularly in urban areas. Governments and private insurers in countries like Japan, Australia, and China are increasingly including viscosupplementation procedures under reimbursement schemes, making the therapy more affordable and accessible to a broader patient base.

Additionally, public health campaigns and orthopedic awareness initiatives are contributing to early OA diagnosis and promoting non-surgical treatment options, supporting the uptake of viscosupplementation.

Technological Advancements and Innovation in HA Formulations

The market is seeing significant advancements in HA-based product formulations, including single-injection and extended-release viscosupplements, which offer greater convenience and longer-lasting results. These innovations are reducing the frequency of clinic visits, lowering overall treatment costs, and increasing patient compliance.

Key manufacturers are investing in R&D to develop next-generation viscosupplements with improved biocompatibility, enhanced pain-relieving properties, and extended efficacy periods, thus making the therapy more appealing to physicians and patients alike.

Country-Level Insights: China, Japan, and India Lead the Market

• China: The largest market in Asia-Pacific for viscosupplementation, driven by a rapidly aging population, expanding urban middle class, and growing healthcare investments. Local players and international companies are actively expanding their distribution networks in China.
• Japan: A mature and highly regulated market with widespread adoption of viscosupplementation among elderly patients. Reimbursement policies and government-supported orthopedic programs have accelerated market penetration.
• India: A fast-growing market supported by increasing OA prevalence, expanding orthopedic infrastructure, and greater affordability of HA injections. Urban centers such as Mumbai, Delhi, and Bangalore are at the forefront of viscosupplementation adoption.

Other notable markets include Australia, South Korea, and Southeast Asian countries such as Thailand, Vietnam, and Malaysia, where awareness and access to treatment are steadily improving.

Market Segmentation

By Product Type:

• Single-Injection Viscosupplements
• Three-Injection Viscosupplements
• Five-Injection Viscosupplements

By Hyaluronic Acid Type:

• Animal-Based HA
• Non-Animal-Based (Biofermented) HA

By Application:

• Knee Osteoarthritis
• Hip Osteoarthritis
• Other Joints (Shoulder, Ankle, etc.)

By End-User:

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers
• Retail Pharmacies

Key Players in the Asia-Pacific Viscosupplementation Market

The competitive landscape of the market features both global giants and regional manufacturers focused on delivering cost-effective and high-performance viscosupplementation products. Major companies include:

• Sanofi
• Seikagaku Corporation
• Anika Therapeutics, Inc.
• Zimmer Biomet Holdings, Inc.
• Fidia Farmaceutici SpA
• LG Chem
• Chugai Pharmaceutical Co., Ltd.
• Bioventus LLC
• Smith & Nephew
• Mylan N.V.

These players are actively forming strategic partnerships, launching new formulations, and expanding their reach across emerging Asia-Pacific economies.

Challenges and Opportunities

Challenges:

• Limited awareness of viscosupplementation in rural and tier-2 cities
• High cost of branded HA formulations
• Regulatory hurdles for new entrants in some countries
• Inconsistent reimbursement policies in certain markets

Opportunities:

• Expansion of telehealth and orthopedic diagnostics
• Growth in medical tourism, especially in India and Thailand
• Rising investments in public orthopedic care infrastructure
• Increasing geriatric care needs and chronic joint disease management

Future Outlook

The Asia-Pacific viscosupplementation market presents robust growth potential due to the high unmet need for non-surgical OA therapies, supportive government policies, and technological innovations. The region is witnessing an evolution in joint health management, where viscosupplementation is poised to play a central role in early-stage osteoarthritis treatment.

According to Renub Research, the shift toward preventive care and early intervention, coupled with increasing disposable incomes and greater healthcare awareness, will continue to drive long-term market expansion across Asia-Pacific.

New Publish Report:

• Global Consumer Electronics Repair And Maintenance Market Size and Growth Trends and Forecast Report 2025-2033
• Hair Care Products Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
• United States Hair Brush Market Forecast 2025–2033
• Air Purifier Market Size, Trends, Growth & Forecast 2025–2033
• Middle East Air Conditioner Market Forecast Report by Type (Window Type, Split Type, Precision Air Conditioning, Variable Refrigerant Flow (VRF)), End User (Residential, Commercial, Industrial) Countries (Saudi Arabia, United Arab Emirates, Oman, Qatar, Kuwait, Others) and Company Analysis 2025-2033
• India Commercial Air Conditioning Market Forecast Report by Type (PAC (Precision Air Conditioners), VRF (Variable Refrigerant Flow) Systems, Chillers, Others (Packaged Systems, Rooftop Units, etc.), Application (IT & Data Centers, Hospitality Industry, Healthcare Facilities, Retail and shopping malls, Others (Educational Institutions, Offices, etc.), Distribution Channel (Small Retailers, Modern Retail/ MBO, Online), Regional Analysis (North India, South India, East India, West India) and Company Analysis 2025-2033
• Africa Air Conditioner Market Forecast 2025–2033
• United States Data Center Cooling Market Forecast Report by Solution (Air Conditioning, Chilling Units, Cooling Towers, Economizer Systems, Liquid Cooling Systems, Control Systems, Others), Services (Consulting, Installation and Deployment, Maintenance and Support), Cooling Types (Room-Based Cooling, Row-Based Cooling, Rack-Based Cooling), Cooling Technology (Liquid-Based Cooling, Air-Based Cooling), Data Center Types (Mid-Sized Data Centers, Enterprise Data Centers, Large Data Centers), Industry (BFSI, IT and Telecom, Research and Educational Institutes, Government and Defense, Retail, Energy, Healthcare, Others) and Company Analysis 2024-2032

Conclusion

The Asia-Pacific Viscosupplementation Market is entering a phase of strong growth, fueled by rising joint health concerns, a growing aging population, and the need for non-invasive treatment options. As healthcare systems across the region evolve and patients seek better quality of life without undergoing surgery, viscosupplementation will increasingly become the therapy of choice.

To explore detailed forecasts, data insights, and strategic market developments, access the full report by Renub Research .

About the Company

Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions. We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our wide clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture. Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.

Media Contact Company Name: Renub Research Contact Person: Rajat Gupta, Marketing Manager Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA) Email: [email protected] Website: https://www.renub.com

Ask ChatGPT